Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03089034

Singapore Cohort of Patients with Advanced Heart Failure

Chronic Heart Failure (CHF) is one of the leading causes of death in Singapore. Although it is well established that CHF patients in Singapore are less likely to be referred to palliative care services than cancer patients, little data is available on end-of-life (EOL) experience of advanced CHF patients in Singapore, including the inter-relationships between patient decision-making, quality of life trajectories, and health and cost consequences.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

National Heart Centre Singapore

Singapore, 169609

About this study

To address this gap and to identify areas for better delivery of end-of-life services to patients with advanced CHF, the investigators propose to enrol a cohort of 300 patients with advanced CHF (New York Heart Association class III and IV), survey the participants every 4 months for a period of two years or till they die, whichever is earlier. The goal of this cohort study is to better understand the relationship between patient preferences, health care access, utilization, costs, and quality of life, and to identify strategies to improve the EOL experience for these patients. It is also important to recognize the significant role of the family in medical decision making in Asia. Previous studies from Singapore reveal that patients want their families to be involved in the decision making process. The role of the family in decision making is consistent with the Chinese culture of interdependency, obligations and filial piety. Decisions regarding treatment are often made by family caregivers, sometimes with little or no input from patients. Given this reality, the investigators will also enroll caregivers of the patients to evaluate their role in decision making for treatment of patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(patients):

  • Age ≥ 21 years old
  • Singaporean or Singapore Permanent Resident
  • Diagnosis of advanced Congestive Heart Failure (New York Heart Association Class III and IV).
  • Intact cognition (of patients ≥60 years of age) as determined by the Montreal Cognitive Assessment. If patient fails the cognitive test, he/she continues to be eligible for the study although self-reported data will no longer be collected. The primary informal caregiver of the patient will be approached for providing consent on behalf of the patient, to allow access to review of patient's medical and billing records

The inclusion criteria (primary informal caregivers)

  • Age ≥ 21 years old
  • Main person or one of the main providing care to the patient (e.g. accompanying patient for doctor's visits, helping the patient with day to day activities)
  • Main person or one of the main ensuring provision of care (e.g. supervision of foreign domestic worker so that the patient is looked after)
  • Main person or one of the main involved in making decisions regarding treatment the patient receives
  • Patient they are caring for is enrolled in the study

The inclusion criteria (physicians) • Patients they are treating are enrolled in the study

Exclusion criteria

(patients):

  • Patients who are not Singaporeans or Singapore Permanent Residents
  • Patients who are ≤21 years of age
  • Patients with psychiatric or cognitive disorders

Exclusion criteria

(caregivers)

  • Foreign domestic workers/ maids will be excluded from this study

Treatment and study plan

Primary outcomes

  1. Change in overall quality of life among patients through the last year of life

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will assess patient's quality of life through FACT-G Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months)

  2. Change in distress among patients through the last year of life

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will assess patients' distress through the distress thermometer

  3. Change in activities of daily living among patients through the last year of life

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will assess limitations in activities of daily living of patients through OARS Multidimensional Functional Assessment Questionnaire

  4. Change in patient's perceived quality of care during the last year of life

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will describe patients' assessment of their own care using a scale used by Ayanian et al (JCO, 2010) that consists of 13 questions.

  5. Change in patient's compliance with treatment regimens and self-care behaviours

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months,24 months)

    Investigators will describe patients' compliance with their self-care behaviour using the Self Care of Heart Failure Index (SCHFI)

  6. Total health care expenditure during the last year of life through analysis of medical bills

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investogators will calculate total health care expenditure during the last year of patient's life as the sum total of expenditures incurred at clinics etc

  7. Change in patients' cognitive status

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will assess patients' cognitive status through Montreal Cognitive Assessment

Secondary outcomes

  1. Change in patient's awareness of hospice palliative care services among heart failure patients

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months )

    Investigators will assess change in patients' awareness of hospice palliative care services by asking them if they are aware and are using hospice palliative care services.

  2. Change in caregiver burden through the last year of life

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will assess caregiver burden through modified Caregiver Reaction Assessment Scale Instrument

  3. Change in caregiver's level of emotional distress through the last year of life

    Time frame: From recruitment to death of patient (baseline, 4 month, 8 months, 12 months, 16 months, 20 months, 24 months)

    Investigators will assess caregiver's anxiety and depression through the Hospital Anxiety and Depression Scale (HADS).

  4. Caregiver's perception of patient's end-of-life care assessed after patient's death

    Time frame: 8 weeks bereavement

    Investigators will assess caregiver perceived quality of end-of-life care through CEQUEL.

Sponsors and collaborators

Lead sponsor

Duke-NUS Graduate Medical School

Other

Collaborators

  • National Heart Centre Singapore
  • Singapore General Hospital

Registry information

Acronym: SCOPAH

Important dates

Study start
2017
Primary completion
2025
Study completion
2025
First posted
Mar 24, 2017
Registry last updated
Feb 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.